EN | UA
EN | UA

Help Support

Back

Drug targets for the treatment of rheumatoid arthritis

Drug targets for the treatment of rheumatoid arthritis Drug targets for the treatment of rheumatoid arthritis
Drug targets for the treatment of rheumatoid arthritis Drug targets for the treatment of rheumatoid arthritis

Rheumatoid arthritis (RA) is a chronic inflammatory disorder with an estimated prevalence of 0.5-1% of the population worldwide; it is also reported that women are more affected than men are. [1]. RA is characterized by joint inflammation, synovial proliferation and destruction of articular cartilage. Immune complexes composed of IgM activate complement and release cytokines (mainly TNFα and IL-1) which are chemotactic for neutrophils. These inflammatory cells secrete lysosomal enzymes, which damage cartilage and erode bone, while PGs produced in the process cause vasodilatation and pain.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: